Literature DB >> 3284483

Intravenous immunoglobulin for prophylaxis of neonatal sepsis in premature infants.

A Stabile1, S Miceli Sopo, V Romanelli, M Pastore, M A Pesaresi.   

Abstract

The incidence of sepsis, mortality due to sepsis, total mortality, and minor infections was evaluated in a group of 46 premature newborn infants who were treated with intravenous immunoglobulins. They were compared with an untreated control group. No significant differences were observed between the two groups.

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3284483      PMCID： PMC1778825          DOI： 10.1136/adc.63.4.441

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN： 0003-9888            Impact factor:   3.791


  5 in total

1.  The effect of monthly gamma-globulin administration on morbidity and mortality from infection in premature infants during the first year of life.

Authors:  J AMER; E OTT; F A IBBOTT; D O'BRIEN; C H KEMPE
Journal:  Pediatrics       Date:  1963-07       Impact factor: 7.124

2.  Intravenous immunoglobulin for prevention of sepsis in preterm and low birth weight infants.

Authors:  K N Haque; M H Zaidi; S K Haque; H Bahakim; M el-Hazmi; M el-Swailam
Journal:  Pediatr Infect Dis       Date:  1986 Nov-Dec

Review 3.  Neonatal septicemia.

Authors:  M Eriksson
Journal:  Acta Paediatr Scand       Date:  1983-01

Review 4.  Immunotherapy of neonatal septicemia.

Authors:  M C Yoder; R A Polin
Journal:  Pediatr Clin North Am       Date:  1986-06       Impact factor: 3.278

5.  [Immunoglobulin substitution in the treatment of neonatal septicemia].

Authors:  D Sidiropoulos; U Böhme; G von Muralt; A Morell; S Barandun
Journal:  Schweiz Med Wochenschr       Date:  1981-10-31
  5 in total
  11 in total

1.  Intravenous immunoglobulin for prophylaxis of nosocomial sepsis.

Authors:  A Atici; M Satar; A Karabay; M Yilmaz
Journal:  Indian J Pediatr       Date:  1996 Jul-Aug       Impact factor: 1.967

Review 2.  New and old aspects of immunoglobulin application. The use of intravenous IgG as prophylaxis and for treatment of infections.

Authors:  L Hammarström; C I Smith
Journal:  Infection       Date:  1990 Sep-Oct       Impact factor: 3.553

Review 3.  Current status of intravenous immunoglobulin in preventing or treating neonatal bacterial infections.

Authors:  L E Weisman; D F Cruess; G W Fischer
Journal:  Clin Rev Allergy       Date:  1992 Spring-Summer

Review 4.  Treatment of sepsis with IgG in very low birthweight infants.

Authors:  A Whitelaw
Journal:  Arch Dis Child       Date:  1990-04       Impact factor: 3.791

Review 5.  Intravenous immunoglobulin for secondary immunodeficiency.

Authors:  P L Yap
Journal:  Blut       Date:  1990-01

6.  Neonatology --then and now. Neonatal sepsis (1960). Two outbreaks of neonatal skin sepsis caused by Staphylococcus aureus, phage type 71.

Authors:  C H Howells; H E Jones
Journal:  Arch Dis Child       Date:  1988-12       Impact factor: 3.791

Review 7.  Pharmacokinetic modeling of therapies for systemic lupus erythematosus.

Authors:  Xiaoyan Yang; Catherine M T Sherwin; Tian Yu; Venkata K Yellepeddi; Hermine I Brunner; Alexander A Vinks
Journal:  Expert Rev Clin Pharmacol       Date:  2015-07-09       Impact factor: 5.045

8.  Intravenous immunoglobulin for preventing infection in preterm and/or low birth weight infants.

Authors:  Arne Ohlsson; Janet B Lacy
Journal:  Cochrane Database Syst Rev       Date:  2020-01-29

Review 9.  Use of intravenous immune globulin in newborn infants.

Authors:  G W Fischer
Journal:  Clin Exp Immunol       Date:  1994-07       Impact factor: 4.330

10.  Administration of intravenous immunoglobulins for prophylaxis or treatment of infection in preterm infants: meta-analyses.

Authors:  J B Lacy; A Ohlsson
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1995-05       Impact factor: 5.747
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.